Where Organoid Research & Drug Discovery Thrive
The global biotech industry is concentrated in premier hubs around the world where world-class research institutions, major pharmaceutical companies, and innovative startups collaborate to advance organoid technology, organ-on-chip systems, and next-generation drug discovery platforms. Explore the leading biotech ecosystems driving personalized medicine and pharmaceutical innovation.
North American Biotech Hubs
Boston, MA
America's leading biotech hub. Over 800 biotech companies, major pharma headquarters, and world-class research institutions driving organoid research and drug discovery innovation.
Explore Boston →San Francisco, CA
The synthetic biology capital. Over 3,000 biotech companies with exceptional computational biology expertise and AI-driven drug discovery innovation.
Explore San Francisco →San Diego, CA
The immunotherapy & precision medicine hub. Over 1,500 biotech companies specializing in cancer organoids and personalized medicine platforms.
Explore San Diego →New York, NY
Translational medicine center. Over 1,200 biotech companies with major medical centers and research institutions advancing clinical translation.
Explore New York →Los Angeles, CA
Regenerative medicine hub. Over 800 biotech companies focused on organ regeneration and tissue engineering innovation.
Explore Los Angeles →Seattle, WA
Computational biology hub. Over 600 biotech companies with world-class software engineering talent driving AI-powered drug discovery.
Explore Seattle →European & International Biotech Hubs
London, UK
Europe's biotech capital. Over 500 companies with world-leading stem cell research and regenerative medicine innovation.
Explore London →Basel, Switzerland
Global pharma powerhouse. Home to Novartis, Roche, and 100+ pharmaceutical companies driving world-class drug discovery innovation.
Explore Basel →Berlin, Germany
Europe's emerging biotech hub. Over 400 biotech companies with vibrant startup ecosystem and strong government support.
Explore Berlin →Tokyo, Japan
Asia's biotech leader. Over 300 biotech companies specializing in regenerative medicine and precision medicine for aging-related diseases.
Explore Tokyo →Why These Biotech Hubs Matter
The world's leading biotech hubs concentrate research expertise, pharmaceutical innovation, and advanced manufacturing capabilities. These regions drive the development of breakthrough organoid technologies, organ-on-chip systems, and personalized medicine platforms that are transforming drug discovery and clinical translation globally.
By understanding the strengths of each biotech hub—from Boston's regulatory expertise to San Francisco's synthetic biology focus, Basel's pharmaceutical leadership, and Tokyo's regenerative medicine innovation—researchers, entrepreneurs, and pharma companies can identify the best partnerships and resources for advancing their organoid and organ-on-chip projects.